-
DAT SPECT data of Parkinson’s disease patients with and without REM Sleep Pathology: A report from the DeNoPa cohort
-
Dat-SPECT in multiple system atrophy (MSA)
-
Day case initiation of subcutaneous apomorphine in people with Parkinson’s disease: A retrospective analysis from a UK teaching hospital
-
DBS of the STN in 44 patients with Parkinson’s disease – Radiological and clinical outcome
-
DBS outcomes in a mixed cohort of dystonia: A single center experience
-
DBS programming requirements and longevity
-
DBS related on-state freezing of gait – A case series
-
DBS targeting: Validation of 3T MR image guided targeting using post-mortem 17T MR microscopy
-
De novo mutations in PDE10A cause childhood-onset chorea with bilateral striatal lesions
-
Deceleration capacity of heart rate indicates autonomic dysfunction in patients with PSP
-
Decline in drawing ability associated with frontal dysfunction after subthalamic nucleus deep brain stimulation in Parkinson’s disease
-
Deep brain stimulation effect on the quality of life of individuals with Parkinson’s disease
-
Deep brain stimulation in a Parkinsonian patient with sever psychiatric complication
-
Deep brain stimulation in early stage Parkinson’s disease: Is it disease modifying?
-
Deep brain stimulation in the STN of a Parkinsonian rat model overexpressing human A53T α-synuclein in the substantia nigra – A proof of principle
-
Deep brain stimulation in the treatment of cerebellar tremor in young patients
-
Deep brain stimulation in three patients with dystonia and severe cerebellar atrophy
-
Deep brain stimulation may lead to dramatic worsening of slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature
-
Deep brain stimulation of the dentate nucleus improves ataxia and modulates cortical excitability
-
Deep brain stimulation of the globus pallidus interna improves performance in complex oculomotor tasks
-
Deep brain stimulation of the locomotor mesencephalic region in rats with lesioned sensorimotor cortex: A model of functional motor recovery after stroke
-
Deep brain stimulation outcomes for dystonia in adult and pediatric patients at Gillette Children’s Specialty Healthcare
-
Defective ubiquitinated mitochondria accumulation in aged Parkinsonian LRRK2R1441G knockin mice
-
Defective visual perception in patients with Parkinson’s disease: The impairment of preattentive visual processing in the normal intellectual patients
-
Deficiency of HGprt in Lesch-Nyhan disease is associated with abnormal dopaminergic neurodevelopment in vivo
-
Deficits in sensorimotor networks in functional movement disorders: A graph-theory based network analysis
-
Defining the pathology underlying cortico-basal syndrome: A European study
-
Deletions at 22q11.2 in idiopathic Parkinson’s disease: A combined analysis of GWAS data
-
Dementia in adult type 2 diabetes patients – An analysis from the multicenter German/Austrian diabetes patient follow-up registry DPV
-
Dementia in Parkinson’s disease is associated with increased diffusivity in amygdala and external capsule
-
Dementia in Parkinson’s disease: Is male gender a risk factor?
-
Demographic and phenotypic comparison of Huntington’s disease in Europe and North America: Data from REGISTRY and COHORT, two prospective observational cohort studies
-
Demographic feature and clinical characteristic of patients with Parkinson’s disease in Isfahan, Iran
-
Density of metabotropic glutamate receptors subtype 1 in de novo patients with Parkinson’s disease using 11C-ITMM PET
-
Depression and anxiety in Parkinson’s disease with rapid eye movement sleep behavior disorder
-
Depression and apathy in restless legs syndrome
-
Depression and clinical progression in spinocerebellar ataxias
-
Depression, anxiety, and apathy in Parkinson’s disease: Insights from neuroimaging studies
-
Depressive disorders in Parkinson’s disease and Alzheimer’s disease
-
Detailed evaluation of dyskinesias using multiple endpoints in a randomized, placebo-controlled trial of Parkinson’s disease patients with motor fluctuations
-
Detailed proteomic analysis of early PD brain highlights altered expression of mitochondrial proteins as an important event in sporadic PD
-
Detecting brainstem changes in Parkinson’s disease using quantitative MRI
-
Detection of leucine-rich repeat kinase 2 in human biofluids
-
Detection of primary olfactory cortex dysfunction in early-stage Parkinson’s disease
-
Detrusor overactivity is associated with frontal dysfunction in patients with Parkinson’s disease?
-
Developing a new home monitoring device for dyskinesia in Parkinson’s disease
-
Developing palliative care clinics for patients with advanced Parkinson’s disease: Practical approaches, challenges, and experiences
-
Development and external validation of a prognostic model of mortality in Parkinson’s disease
-
Development of a human neuroblastoma model of pantothenate kinase-associated neurodegeneration
-
Development of a nanoherbaceutical containing natural L-DOPA from mucuna pruriens for the prevention and treatment of Parkinson’s disease in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced animal model
-
Development of a nanoherbaceutical formulation containing compound extracts from huperzia serrata, mucuna pruriens and withania somnifera for the prevention and treatment of Parkinson’s disease
-
Development of a tool for assessment of embarrassment due to dystonia
-
Development of hyperkinesias after long term pallidal stimulation for dystonia
-
Development of the UK hereditary spastic paraplegia registry: Analysis of SPAST patients reveals high rate of psychiatric comorbidities
-
Developmental movement patterns resemble movement disorder features in healthy babies and toddlers
-
Diagnosis and management of dementia with Lewy bodies: Influence of concomitant cerebrovascular disease
-
Diagnostic accuracy of common bedside ataxia examination tests
-
Diagnostic performance of the Spanish version of the 19-items wearing-off questionnaire in Mexican patients with PD
-
Diagnostic reliability of clinical symptoms in patients with incomplete manifestation of the triad of parkinsonism compared to 18F-DOPA PET-CT MRI imaging
-
Diagnostic sensitivity and remote monitoring of motor and non-motor dysfunction in Parkinson’s disease
-
Diagnostic value of a new coronal examination plane in transcranial nigral sonography and of additional M-mode tremor frequency determination for the differentiation of idiopathic Parkinson’s disease and essential tremor
-
Diagnostic value of cardiac 123I-MIBG SPECT and CT co-registration in PD and MSA-P
-
Diagnostic value of combined acute levodopa challenge and olfactory testing to predict Parkinson’s disease diagnosis
-
Diaphragmatic dystonia in a patient that presents with Meige syndrome and disordered breathing
-
Difference between physiologically defined subthalamic nucleus target and final lead placement: Influence in clinical outcome
-
Difference of REM sleep behavior disorder between the onset of before and after Parkinson’s disease
-
Differences between responders and non-responders of Istradefylline for the wearing off in Parkinson’s disease
-
Differences in MDS-UPDRS scores based on Hoehn and Yahr stage and disease duration: Results of a large international multicenter study of 3206 patients (the QUALPD study)
-
Differences in physicians’ understanding of biologic and biosimilar medicines in the USA and Europe
-
Differences in processing proprioceptive input from the neck muscles may explain the benefit from sensory tricks in patients with idiopathic cervical dystonia
-
Differences of gut bacterial community relate to pathology progress in Parkinson’s disease
-
Different patterns of spontaneous brain activity between tremor-dominant and postural instability/gait difficulty subtypes of Parkinson’s disease: A resting-state fMRI study
-
Differential clinical outcomes in unifocal vs. multifocal premotor rTMS for Parkinson’s disease: A randomized trial
-
Differential effects of tango, treadmill, and stretching interventions on gait in people with Parkinson’s disease
-
Differential expression of cerebral dopamine neurotrophic factor (CDNF) in the hippocampus and in the striatum of LRRK-2 mutant rat model of Parkinson’s disease
-
Differential vulnerability to α-synuclein pathology among neuronal subpopulations
-
Differentiated versus undifferentiated mesenchymal stem cell therapy in paraquat model of Parkinson’s disease
-
Differentiating Parkinson’s disease from advanced essential tremor using EMG
-
Diffusion tensor imaging (DTI) within the primate caudate nucleus marks dopaminergic (DA) and serotonergic (5-HT) lesions
-
Diffusion tensor imaging biomarkers of nigrostriatal neurodegeneration in early Parkinson’s disease
-
Diffusion tensor imaging in Parkinson’s disease: Review and meta-analysis with clinical considerations and neuroimaring parameters
-
Diffusion tensor imaging of corticospinal tract, cingulum and corpus callosum in Parkinson’s disease (PD) patients
-
Diffusion tensor imaging of the corticospinal tract differentiates Parkinson’s disease (PD) patients from controls
-
Diffusion tensor metrics of thalamic degeneration and postural instability in Parkinson’s disease
-
Digitally captured Archimedes spiral indices correlate with clinical assessment of dystonia severity
-
Digitizing tablet and Fahn-Tolosa-Marín tremor ratings have comparable minimum detectable change
-
Direct assessment of psychosocial measures using eye tracking technology in advanced ALS – Can preserved autonomy and psychological wellbeing modify disease course?
-
Direct comparisons for botulinum neurotoxins in movement disorders
-
DIRECT DBS: A prospective, multi-center clinical trial with blinding for a directional DBS lead
-
Disability is an independent predictor of falls and recurrent falls in people with Parkinson’s disease without a history of falls: A one-year prospective study
-
Discrimination of Parkinson’s disease participants from healthy controls using telephone-quality voice recordings
-
Disease progression and clinical characteristics of Parkinson’s disease patients with type 1 diabetes – An analysis on 18,162 patients from the DPV registry
-
Disease severity is not predictive of the dose required for apomorphine sublingual film (APL-130277) to convert a patient with Parkinson’s disease from OFF to fully ON
-
Disease stage classification of the cerebellar variant of multiple system atrophy based on voxel-based morphometry
-
Disease-related variables effect on depression and anxiety level in Parkinson’s patients
-
Disrupted hubs in functional brain networks in subtype-specific Parkinson’s disease
-
Disrupted motor memory in Parkinson’s disease
-
Disruption of cerebellar connectivity in cervical dystonia
-
Disruption of circadian rhythm function and anti-oxidation via SIRT1-BMAL1 pathway in 6-OHDA induced Parkinson’s disease model
-
Disruption of functional connectivity in Parkinson’s disease patients presenting phonemic fluency impairment
-
Dissecting the molecular mechanisms of Fyn-mediated levodopa induced dyskinesias
-
Distinguishing pseudo-dystonia from dystonia: A case series
-
Distribution of oscillatory activities in MRI confirmed subthalamic nucleus subregions
-
Diurnal variation of levodopa plasma concentration in patients with Parkinson’s disease
-
Diverse effects of alpha-synuclein fibrils on various neuron cell lines, using different buffers
-
DJ-1 regulates intracellular signaling in a highly cell type specific manner
-
Do different tic phenotypes have different responses to comprehensive behavioral intervention for tics (CBIT)?
-
Do environmental factors influence the age at onset of Parkinson’s disease in LRRK2 G2019S carriers?
-
Do mutations in the TGM6 (SCA35) gene cause early-onset Parkinson’s disease?
-
Do predictors of good response to deep brain stimulation in primary cervical movement disorders exist?
-
Do subjective ratings of the Parkinson’s disease sleep scale-2 converge with results from polysomnography in early Parkinson’s disease? – A report from the DeNoPa cohort
-
Do-not-resuscitate utilization in inpatient Parkinson’s disease in the United States
-
Does body mass index influence outcome of deep brain stimulation in Parkinson’s patients?
-
Does cognitive decline contribute to poorer quality of life in incident Parkinson’s disease? A three year follow up
-
Does distance walked after two minutes predict total 6 minute walk test distance in people with Parkinson’s disease?
-
Does dopamine affect the selection of stepping actions in PD?
-
Does GPi-DBS help non motor symptoms in cervical dystonia patients? A retrospective study of 17 patients
-
Does link between fatigue syndrome and camptocormia in patients with Parkinson’s disease exist?
-
Does physical exercise influence the cognitive domains that predict dementia in Parkinson’s disease?
-
Does repetitive transcranial magnetic stimulation (rTMS) affect cognitive function in Parkinson’s disease by modulating high-frequency brain oscillations: A magnetoencephalography (MEG) study
-
Does VIM deep brain stimulation affect swallowing?
-
Dopamine agonist withdrawal syndrome (DAWS) in a tertiary Parkinson’s disease center
-
Dopamine and task-dependent evolution of oscillatory activity in the subthalamic nucleus (STN) and coupling between the STN local field potential and muscle activity in Parkinson’s disease
-
Dopamine D3 receptor Ser9Gly variant is a risk factor for impulse control disorders in Parkinson’s disease
-
Dopamine dysregulation syndrome /DDS/ in LCIG infusion: Successful treatment without interrupting the pump therapy
-
Dopamine modulates learning conflicting action-valence associations in Parkinson’s disease
-
Dopamine reduces Parkinson’s tremor through increased thalamic inhibition
-
Dopamine transporter, depression and anxiety differences between tremor-predominant and non-tremulous PD are already evident within 2 years of PD diagnosis
-
Dopaminergic and metabolic network activities in onset-related subtypes of Parkinson’s disease: A dual-tracer positron emission tomography study
-
Dopaminergic and non-dopaminergic effects on instrumented timed up and go test in patients with Parkinson’s disease
-
Dopaminergic drug management in Parkinson’s disease: Gait and language function show correlation during treatment
-
Dopaminergic medication affects choice bias in Parkinson’s disease
-
Dopaminergic medication effect on speech in Parkinson’s disease: A kinematic study
-
Dopaminergic medicines are alternative drugs for treatment of motor disorders in ischemic stroke
-
Dophaminergic therapy and its influence on the olfactory function of patients with Parkinson’s disease
-
Dorsal simultanagnosia as a cortical sign in the tauopathy spectrum
-
Dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behaviour disorder
-
Dosing of abobotulinumtoxinA and muscle selection in patients with simple patterns of cervical dystonia
-
Double-blind, placebo-controlled trial of a fermented milk containing multiple probiotic strains and prebiotic fiber for constipation associated with Parkinson’s disease
-
Dropped head syndrome in parkinsonism: Two treatable etiologies not to miss
-
Drp1 inhibition amelioratesα-synuclein-mediated neurodegeneration in rats
-
Drug induced parkinsonism: Role of functional imaging and follow up
-
Drug safety in the pharmacotherapy of Parkinson’s disease
-
Drug-induced parkinsonism in Taiwan
-
DTI in Parkinson’s disease: Asymmetric progression
-
DTI tractographic correlates of weight gain in Parkinson’s disease patients after STN DBS
-
Duloxetine, a serotonin and norepinephrine reuptake inhibitor, reduces daily OFF time in Parkinson’s disease
-
Duodenal levodopa infusion: Safety and efficacy in a 6 years outpatient follow-up
-
Duodopa for the treatment of severe restless legs syndrome
-
Duodopa treatment experience in Oradea
-
Duration of levodopa treatment and prevalence of osteoporosis in patients with Parkinson’s disease
-
Dyadic decision making & decisional satisfaction in advanced Parkinson’s disease
-
Dynamic and static posturographic analysis among fallers and non- faller Parkinson’s disease (PD) patients using Neurocom SMART EquiTest
-
Dynamic dopamine transporter images are helpful for diagnosing parkinsonism
-
Dynamic prediction for multiple repeated measures and event time data: An application to Parkinson’s disease
-
Dynamics in statin use, low density lipoprotein cholesterol levels and Parkinson’s disease. A population-based cohort study using big-data
-
Dyskinesias-reduced-self-awareness and theory of mind in Parkinson’s disease: A novel frame of interpretation
-
Dysphagia in early stage Huntington’s disease (HD) – Pilot observations from a multimodal imaging study
-
Dysregulated macroautophagy and mitochondrial dynamics in PD with glucocerebrosidase mutations
-
Dysregulations of GABAergic neurotransmission in Huntington’s disease brain
-
Dystonia after peripheral nerve injury in DYT1 transgenic rats
-
Dystonia in a medieval scribe: Analysis of Bernard Blancard’s handwriting over four decades
-
Dystonia-deafness syndrome caused by beta -actin gene mutation and the effect of pallidal deep brain stimulation
-
Dystonia, myoclonus, and tremor without epilepsy associated with a mutation in STXBP1
-
Dystonia, tremor, and dystonic tremor
-
DYT16/PRKRA founder mutation causes childhood-onset generalized dystonia in a family from southern Italy
-
DYT2 dystonia – Too rare to be found?
2016 International Congress
June 19-23, 2016. Berlin, Germany.